`

DBV Technologies

Biotechnology Research

Specialities :
Allergy
Food and pediatric allergy
And specific immunotherapy
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$192.21M
size-icon Size
51 - 200

Frequently Asked Questions About DBV Technologies

What does Dbv technologies do?+

DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin. Today, we are focused on exploring...

What are Dbv technologies's specialties? +

Allergy,food and pediatric allergy,and specific immunotherapy

What is Dbv technologies's industry? +

Dbv technologies operates in the Biotechnology research industry.

What is Dbv technologies's revenue? +

Dbv technologies's revenue is 11m - 100m

What is Dbv technologies's company size? +

Dbv technologies has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.